Oncoheroes Biosciences is a biotechnology company exclusively dedicated to discovering and developing therapeutics for childhood cancers. Operating from Boston, the firm assembles its pipeline by in-licensing or acquiring promising compounds from industry and academic groups and then applying its pediatric-specific drug-development expertise. The company also forms co-development partnerships with other biotechs, universities, and foundations to accelerate therapies that align with its child-focused mission. Current plans center on launching and executing clinical trials for several pipeline candidates designed expressly for young patients. This focus addresses the long-standing gap created by adapting adult oncology drugs for children. By concentrating resources on pediatric indications, Oncoheroes aims to bring safer, more effective treatments to market faster. No revenue or patient enrollment figures were disclosed in the article.

Total raised

$1M

Funding rounds

2

Latest round

Equity

Latest activity

Feb 2020